central nervous system, glioma, SEER, Surveillance, Epidemiology, and End Results, chemotherapy, surgery, RADIOTHERAPY
Nasopharyngeal carcinoma, Immune checkpoint inhibitor, Immune-related adverse event, Immunotherapy, Meta-Analysis
Nasopharyngeal carcinoma, Immune checkpoint inhibitor, Immune-related adverse event, Immunotherapy, Meta-analysis